Explore Topics and Trends impacting today's markets

Market volatility in 2022 is likely to be elevated, driven by portfolio allocation decisions as investors react to major changes in the risk management landscape.

Financial and real asset holdings are a huge multiple of one year’s GDP.  Small shifts in portfolio preferences can involve the re-allocation of trillions of dollars, moving markets. 

Many investors and portfolio managers will undoubtedly stay their course in 2022.  Others, though, may consider whether to make changes in their portfolios given (1) the shift toward a more neutral policy at the Federal Reserve, and (2) the abrupt change in the inflation landscape that occurred in 2021, ending over two and half decades of relative price stability.

Real GDP is likely to decelerate materially after the 2021 rebound year.  This is totally natural, as steadier, slower growth typically follows a rapid rebound.  The implications are that the GDP slowdown is unlikely to be related to the shift in Fed policy towards neutral.

The Covid-Omicron impact in 2022 remains unclear.  We are still learning how infection and hospitalization rates will shift with this variant or others that may follow.  However, the policy bias appears to be to avoid a repeat of the spring 2020 shutdowns, which reduces the probability of a return to economic distress.

While measured inflation may abate a little as 2022 progresses, the overall rate of inflation is likely to remain well above central bank targets, suggesting continued pressure for the Federal Reserve to follow-through on its forward guidance to revert to a more neutral policy stance.  Indeed, federal funds futures suggest three to four quarter percentage point rate hikes in 2022 are possible.

Putting this all together, risk management will be key as investors adapt to a more neutral Fed and a changed inflation landscape.  Potential asset flows due to portfolio shifts, essentially a Great Re-Balancing, are likely to serve as the key drivers for elevated market volatility in 2022.



OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.

All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).

©2022 CME Group Inc. All rights reserved